These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18436737)

  • 21. Study on antimicrobial susceptibility of bacteria causing neonatal infections: a 12 year study (1987-1998).
    Yu JL; Wu SX; Jia HQ
    Singapore Med J; 2001 Mar; 42(3):107-10. PubMed ID: 11405560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV; Hawkey PM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unmet medical needs in antibacterial therapy.
    Rice LB
    Biochem Pharmacol; 2006 Mar; 71(7):991-5. PubMed ID: 16280121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
    Lode H
    Clin Microbiol Infect; 2005 Oct; 11(10):778-87. PubMed ID: 16153251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of antimicrobial resistance pattern of nosocomial and community bacterial pathogens at a teaching hospital in Tehran,Iran.
    Zamani S; Nasiri MJ; Khoshgnab BN; Ashrafi A; Abdollahi A
    Acta Med Iran; 2014; 52(3):182-6. PubMed ID: 24901718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.
    Pitiriga V; Vrioni G; Saroglou G; Tsakris A
    Adv Ther; 2017 Apr; 34(4):854-865. PubMed ID: 28303388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic stewardship : A programmatic approach to improved antimicrobial management].
    Müller M; Lehmann P; Willy C
    Unfallchirurg; 2017 Jul; 120(7):540-548. PubMed ID: 28608289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial Stewardship and Education, the Role of Pharmacists in the University Hospital].
    Yoshinaga N; Hisato A; Kitai M; Hisamitsu Y; Sango H; Yoshida K
    Yakugaku Zasshi; 2021; 141(11):1253-1255. PubMed ID: 34719547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty.
    Garvin KL; Hinrichs SH; Urban JA
    Clin Orthop Relat Res; 1999 Dec; (369):110-23. PubMed ID: 10611866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of antibiotic resistance of Enterobacteriaceae strains isolated in community- and hospital-acquired infections in teaching hospitals of Hamadan, west of Iran.
    Hashemi SH; Esna-Ashari F; Tavakoli S; Mamani M
    J Res Health Sci; 2013 May; 13(1):75-80. PubMed ID: 23772019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region.
    Alothman A; Al Thaqafi A; Al Ansary A; Zikri A; Fayed A; Khamis F; Al Salman J; Al Dabal L; Khalife N; AlMusawi T; Alfouzan W; El Zein S; Kotb R; Ghoneim Y; Kanj SS
    Int J Infect Dis; 2020 Dec; 101():249-258. PubMed ID: 33031939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications.
    Bert F; Andreu M; Durand F; Degos F; Galdbart JO; Moreau R; Branger C; Lambert-Zechovsky N; Valla D
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):10-5. PubMed ID: 12582738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?
    Enne VI
    J Antimicrob Chemother; 2010 Feb; 65(2):179-82. PubMed ID: 20008449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality pneumonia care: distinguishing community-acquired from health care-associated pneumonia.
    Shorr AF; Owens RC
    Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S8-14. PubMed ID: 19502227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.